Laboratory Diagnosis of COVID-19 in Timor-Leste: Needs and Challenges

preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Timor-Leste rapidly scaled molecular testing for SARS-CoV-2 from minimal pre-pandemic capacity to a nation-wide network reaching all referral hospital. The National Health Laboratory (NHL) in Dili—supported by the Ministry of Health (MoH), WHO, and partnership development stood up RT-PCR on existing and newly procured platforms, extended testing via GeneXpert in referral and municipal laboratories, and implemented data systems and workforce surge strategies. Despite achievements, over 200,000 molecular tests during COVID-19 periods; peak national capacity around 500-700 tests/day, constraints in human resources, procurement, logistics, and quality management were persistent. Consolidating gains now offers opportunities to institutionalize multiplex respiratory testing, integrate middleware/LIMS for connectivity, and extend molecular diagnostics to other priority pathogens.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0